Disc Medicine, Inc. Common Stock (IRON) Stock Price
IRONStock
$82.41+34.12%52W
Market Cap$3.16B
P/E—
PEG Ratio—
Div yield—
Beta0.90
IRON Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)14.28%
Price vs S&P 500 (4W)5.37%
VGM Score65.06
IRON Earnings Surprise History
Q2 25-1.58est. -1.14
Q3 25-1.77est. -1.46
Q4 25-1.62est. -1.70
Q1 26-1.65est. -1.73
Q2 26-1.54est. -1.77
IRON Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.32
4.32
4.32
4.32
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IRONDisc Medicine, Inc. Common Stock | — | — | B | $82.41 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Disc Medicine, Inc. Common Stock
Disc Medicine is a clinical-stage biopharmaceutical company developing treatments for hematologic disorders through modulation of heme biosynthesis and iron homeostasis. The company's pipeline includes bitopertin for erythropoietic porphyrias, DISC-0974 for anemia in myelofibrosis and chronic kidney disease, and DISC-3405 for polycythemia vera. These programs target conditions with significant unmet medical needs and substantial market opportunities.